Sanuwave Health will host a conference call on May 9, 2025, to discuss Q1 financial results.
Quiver AI Summary
Sanuwave Health, Inc. will hold a conference call on May 9, 2025, at 8:30 AM ET to discuss its Q1 2025 financial results. Participants can join by dialing toll-free or international numbers or by using a link for instant access. The call will include materials available on the company's investor website, and a replay will be accessible until May 30, 2025. Sanuwave focuses on non-invasive medical technologies for wound care and tissue regeneration, aiming to enhance the body's healing processes through its innovative products. The press release also includes forward-looking statements and cautions regarding potential risks and uncertainties that may affect the company's future performance.
Potential Positives
- Sanuwave Health is set to present its Q1 2025 financial results during a live conference call, signaling transparency and communication with investors.
- The company showcases its position as a leader in next-generation FDA-approved wound care products, highlighting its commitment to innovation in healthcare.
- The availability of materials on the company's website facilitates access to important information for stakeholders, enhancing corporate governance.
Potential Negatives
- The press release includes a disclaimer about forward-looking statements, indicating potential uncertainty regarding future performance, which may raise concerns among investors.
- The mention of regulatory oversight and competition as risks could signal challenges that the company faces in maintaining its market position and compliance.
- Future financial results are described as uncertain, which could lead to a lack of investor confidence or interest in the upcoming conference call.
FAQ
When will Sanuwave Health present its Q1 2025 financial results?
Sanuwave Health will present its Q1 2025 financial results on Friday, May 9, 2025, at 8:30 AM (ET).
How can I access the live conference call?
Access the live conference call by dialing 1-800-245-3047 toll-free or 1-203-518-9765 for international calls.
Where can I find the materials for the conference call?
The materials for the conference call will be available on Sanuwave's website at www.sanuwave.com/investors.
Is there a replay available for the conference call?
Yes, a replay of the conference call will be available through May 30, 2025, at 1-844-512-2921 or 1-412-317-6671.
What does Sanuwave Health specialize in?
Sanuwave Health specializes in next-generation FDA-approved wound care products and regenerative medicine technologies for various medical conditions.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SNWV Insider Trading Activity
$SNWV insiders have traded $SNWV stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SNWV stock by insiders over the last 6 months:
- MANAGEMENT INC. OPALEYE has made 2 purchases buying 7,998 shares for an estimated $203,875 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Full Release
EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8:30 AM (ET) to present its Q1 2025 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-245-3047
Toll/International: 1-203-518-9765
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event:
https://viavid.webcasts.com/starthere.jsp?ei=1714486&tp_key=88406b4795
Materials for the conference call will be included on the Company’s website at
www.sanuwave.com/investors
.
A replay will be made available through May 30, 2025:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11158734
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
